Literature DB >> 3768709

Hippocampal membrane alteration in Alzheimer's disease.

G S Zubenko.   

Abstract

The biophysical properties of hippocampal membrane preparations from patients with Alzheimer's disease were examined by fluorescence spectroscopy using the membrane lipid probe 1,6-diphenyl-1,3,5-hexatriene (DPH) and its cationic derivative 1-[4-(trimethylamino)-phenyl]-6-phenyl-1,3,5-hexatriene (TMA-DPH). Results of these experiments suggest that Alzheimer's disease is associated with a biophysical alteration in superficial regions of brain cell membranes, as reflected by the mobility of TMA-DPH. In contrast, no change in the mobility of DPH, which preferentially localizes to the hydrocarbon core, was observed. Although a trend was observed for TMA-DPH mobility to parallel histopathologic severity in hippocampal specimens, the biophysical changes did not appear to reflect a loss of neuronal membranes relative to glial membranes or the presence of senile plaques or neurofibrillary tangles.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768709     DOI: 10.1016/0006-8993(86)91552-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  Amyloid beta peptide membrane perturbation is the basis for its biological effects.

Authors:  J N Kanfer; G Sorrentino; D S Sitar
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminium on platelet and erythrocyte membranes.

Authors:  S J van Rensburg; M E Carstens; F C Potocnik; A K Aucamp; J J Taljaard; K R Koch
Journal:  Neurochem Res       Date:  1992-08       Impact factor: 3.996

3.  Inheritance pattern of platelet membrane fluidity in Alzheimer disease.

Authors:  A Chakravarti; S A Slaugenhaupt; G S Zubenko
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

4.  Neural membrane phospholipids in Alzheimer disease.

Authors:  K Wells; A A Farooqui; L Liss; L A Horrocks
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

5.  Effects of membrane fluidity on [3H]TCP binding to PCP receptors.

Authors:  F R DePietro; J C Byrd
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

Review 6.  Dietary lipids in the aetiology of Alzheimer's disease: implications for therapy.

Authors:  Janelle L Cooper
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Interaction of amyloid beta-protein with anionic phospholipids: possible involvement of Lys28 and C-terminus aliphatic amino acids.

Authors:  A Chauhan; I Ray; V P Chauhan
Journal:  Neurochem Res       Date:  2000-03       Impact factor: 3.996

8.  Quantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain.

Authors:  Paul H Axelsen; Robert C Murphy
Journal:  J Lipid Res       Date:  2009-09-18       Impact factor: 5.922

9.  Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain.

Authors:  T K Makar; A J Cooper; B Tofel-Grehl; H T Thaler; J P Blass
Journal:  Neurochem Res       Date:  1995-06       Impact factor: 3.996

10.  Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disorders.

Authors:  Genaro G Ortiz; Gloria A Benítez-King; Sergio A Rosales-Corral; Fermín P Pacheco-Moisés; Irma E Velázquez-Brizuela
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.